Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients-Reference-Cited by-同舟云学术

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

Published:2010-09-02 Issue:4 Volume:26 Page:1346-1354
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Kirkpantur A.,Balci M.,Gurbuz O. A.,Afsar B.,Canbakan B.,Akdemir R.,Ayli M. D.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/26/4/1346/5312263/gfq539.pdf

Reference57 articles.

1. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

2. Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study

3. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study

4. Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis;npj Cardiovascular Health;2024-08-21

2. Preoperative inflammatory biomarkers reveal renal involvement in postsurgical mortality in hip fracture patients: an exploratory study;Frontiers in Immunology;2024-06-10

3. Genetic Association of Serum Calcium, Phosphate, Vitamin D, Parathyroid Hormone, and FGF23 with the Risk of Aortic Stenosis;2024-03-11

4. Cognitive Impairment in Renal Replacement Therapy: Comparison between Methods;Journal of Clinical Nephrology;2024-01-29

5. Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease;Frontiers in Endocrinology;2023-12-19